This Popular Weed Killer Wreaks Havoc on Animals and Is Probably Hurting Us, Too

The EPA releases a damning report about atrazine—and kicks the can to the next administration.

<a href="hhttp://www.shutterstock.com/pic-107961041/stock-photo-crop-duster-spraying-corn.html?src=YO8eMJxY2RIdppzCwvFimw-1-34">David Malik</a>/Shutterstock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Atrazine, the second most commonly used herbicide in the United States, is mainly used to control weeds in the corn blanketing much of the Midwest. The chemical also routinely turns up in streams and drinking water. And according to a new Environmental Protection Agency preliminary risk assessment, it may be doing serious harm to fish, animals, and amphibians, even at extremely low exposure levels. 

Atrazine may be doing serious harm to fish, animals, and amphibians, even at extremely low levels.

To figure out whether a toxin is damaging ecosystems, EPA scientists crunch data from peer-reviewed research to establish what they call “levels of concern”—the threshold above which the chemical can be expected to cause harm. In the areas where it is most commonly used, mainly the Midwestern corn belt, atrazine turns up in the environment at rates that exceed established levels of concern “by as much as 22, 198, and 62 times for birds, mammals, and fish, respectively,” the report concluded.

As for amphibians like frogs, the report found “potential for chronic risk” from atrazine at real-world exposure levels—not rapid death, like what a roach might experience after a blast of Raid, but long-term, subtle damage, like an impeded ability to reproduce. The EPA paper cited several studies by Tyrone Hayes, an integrative biologist at the University of California-Berkeley who has found that miniscule amounts of the chemical can trigger sex changes in frogs. In response to his research, atrazine’s maker, the agrichemical giant Syngenta, embarked on a spirited, sustained effort to discredit him, detailed in a 2012 Mother Jones piece and a 2014 New Yorker feature.

I asked Hayes whether he felt vindicated by the EPA’s new report. “Asking me if I feel vindicated is like asking someone who’s been in jail for 10 years for something he didn’t do whether he feels vindicated when he gets out,” he said.

Syngenta, for its part, rejects the concerns raised by the EPA. “The draft ecological risk assessment drew conclusions based on a number of scientific errors and flawed interpretations,” a company spokesperson wrote in an email. “This draft ecological risk assessment is inconsistent with a number of EPA’s previous conclusions as well as assessments by other regulatory agencies around the world.”

The European Union banned atrazine in 2004, citing its potential to contaminate water and harm ecosystems. And this latest EPA report suggests the US government might also consider reining in use of the chemical. But probably not anytime soon. The agency has been reviewing atrazine’s registration since 2009, and the wheels turn slowly. On Monday, the EPA published the assessment in the Federal Register, opening a 60-day period for public comment. An EPA spokeswoman says it won’t be finalized until 2017—meaning no regulatory action until well after the presidential election.

A government panel found that atrazine had “suggestive evidence of carcinogenic potential” for ovarian cancer, non-Hodgkin’s lymphoma, hairy-cell leukemia, and thyroid cancer.

Meanwhile, the EPA is also mulling an even more heated issue: atrazine’s impact on human health. The agency expects to release its human-health assessment “later in 2016,” a spokesperson said. Back in 2011, the EPA released the final deliberations by a panel of independent scientists it had convened to address the topic. Its conclusions were not comforting. (Here’s my summary from the time.) The panel found that atrazine had “suggestive evidence of carcinogenic potential” for ovarian cancer, non-Hodgkin’s lymphoma, hairy-cell leukemia, and thyroid cancer, and that “there is inadequate evidence” to determine whether atrazine causes prostate cancer, breast cancer, liver cancer, esophageal cancers, and childhood cancers.

A recent paper by Texas A&M and Iowa State University researchers looked at research published since 2000 and concluded that “higher concentrations of atrazine in drinking water” have been associated with a variety of birth defects in people.

“The science has been settled for a long time,” Hayes told me. “Now it’s politics and economics.” Apparently, it will be up to a Clinton or, gulp, Trump administration to do something about it.

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate